Celularity Inc (CELU) stock
CELUNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.68−0.07 (-8.81%)
Close on Nov 12, 2026Market cap $22.22MP/E –Yield –
Celularity cash
Cash and short-term investments held at the end of each period.
Celularity's cash was $586.00K at Jun 30, 2026. For fiscal 2025 it was $6.18M, down 43.7% from the year before. The highest annual figure on record is $69.51M in fiscal 2020.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.18M | -43.7% |
| FY2024 | Dec 31, 2024 | $10.98M | +8.0% |
| FY2023 | Dec 31, 2023 | $10.16M | -64.7% |
| FY2022 | Dec 31, 2022 | $28.80M | -44.7% |
| FY2021 | Dec 31, 2021 | $52.08M | -25.1% |
| FY2020 | Dec 31, 2020 | $69.51M | +59.8% |
| FY2019 | Dec 31, 2019 | $43.51M | +175991.8% |
| FY2018 | Dec 31, 2018 | $24.71K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $586.00K | -94.6% |
| Q1 FY2026 | Mar 31, 2026 | $368.00K | -96.4% |
| Q4 FY2025 | Dec 31, 2025 | $6.18M | -43.7% |
| Q3 FY2025 | Sep 30, 2025 | $120.00K | -98.8% |
| Q2 FY2025 | Jun 30, 2025 | $10.94M | +3.6% |
| Q1 FY2025 | Mar 31, 2025 | $10.30M | -13.8% |
| Q4 FY2024 | Dec 31, 2024 | $10.98M | +8.0% |
| Q3 FY2024 | Sep 30, 2024 | $10.33M | -31.6% |
| Q2 FY2024 | Jun 30, 2024 | $10.55M | -41.1% |
| Q1 FY2024 | Mar 31, 2024 | $11.95M | -48.8% |
| Q4 FY2023 | Dec 31, 2023 | $10.16M | -64.7% |
| Q3 FY2023 | Sep 30, 2023 | $15.10M | -73.7% |
| Q2 FY2023 | Jun 30, 2023 | $17.91M | -66.1% |
| Q1 FY2023 | Mar 31, 2023 | $23.36M | -62.8% |
| Q4 FY2022 | Dec 31, 2022 | $28.80M | -44.7% |
| Q3 FY2022 | Sep 30, 2022 | $57.48M | -34.3% |
| Q2 FY2022 | Jun 30, 2022 | $52.83M | +130.5% |
| Q1 FY2022 | Mar 31, 2022 | $62.86M | +64.9% |
| Q4 FY2021 | Dec 31, 2021 | $52.08M | -25.1% |
| Q3 FY2021 | Sep 30, 2021 | $87.44M | -9.0% |
| Q2 FY2021 | Jun 30, 2021 | $22.92M | +3097.9% |
| Q1 FY2021 | Mar 31, 2021 | $38.11M | +7448.0% |
| Q4 FY2020 | Dec 31, 2020 | $69.51M | +59.8% |
| Q3 FY2020 | Sep 30, 2020 | $96.03M | +9270.8% |
| Q2 FY2020 | Jun 30, 2020 | $716.70K | -38.7% |
| Q1 FY2020 | Mar 31, 2020 | $504.93K | +2574.3% |
| Q4 FY2019 | Dec 31, 2019 | $43.51M | +175991.8% |
| Q3 FY2019 | Sep 30, 2019 | $1.02M | +10738.8% |
| Q2 FY2019 | Jun 30, 2019 | $1.17M | – |
| Q1 FY2019 | Mar 31, 2019 | $18.88K | – |
| Q4 FY2018 | Dec 31, 2018 | $24.71K | – |
| Q3 FY2018 | Sep 30, 2018 | $9.46K | – |
See a number that looks wrong?